Evidence map›Paper›PMID 31632194›Full record

ReviewCancer cell international2019

Why are olfactory ensheathing cell tumors so rare?

Mariyam Murtaza, Anu Chacko, Ali Delbaz, Ronak Reshamwala, Andrew Rayfield, Brent McMonagle, James A St John, Jenny A K Ekberg

Abstract readReview
In one paragraph

Review in Cancer cell international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mariyam Murtaza1Griffith Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111 Australia.
Anu Chacko1Griffith Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111 Australia.
Ali Delbaz1Griffith Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111 Australia.
Ronak Reshamwala1Griffith Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111 Australia.
Andrew Rayfield1Griffith Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111 Australia.
Brent McMonagle4Department of Otolaryngology-Head and Neck Surgery, Gold Coast University Hospital, 1 Hospital Boulevard, Southport, QLD 4215 Australia.
James A St John *1Griffith Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111 Australia.
Jenny A K Ekberg *1Griffith Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111 Australia.ORCID 0000-0001-5151-4966

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The glial cells of the primary olfactory nervous system, olfactory ensheathing cells (OECs), are unusual in that they rarely form tumors. Only 11 cases, all of which were benign, have been reported to date. In fact, the existence of OEC tumors has been debated as the tumors closely resemble schwannomas (Schwann cell tumors), and there is no definite method for distinguishing the two tumor types. OEC transplantation is a promising therapeutic approach for nervous system injuries, and the fact that OECs are not prone to tumorigenesis is therefore vital. However, why OECs are so resistant to neoplastic transformation remains unknown. The primary olfactory nervous system is a highly dynamic region which continuously undergoes regeneration and neurogenesis throughout life. OECs have key roles in this process, providing structural and neurotrophic support as well as phagocytosing the axonal debris resulting from turnover of neurons. The olfactory mucosa and underlying tissue is also frequently exposed to infectious agents, and OECs have key innate immune roles preventing microbes from invading the central nervous system. It is possible that the unique biological functions of OECs, as well as the dynamic nature of the primary olfactory nervous system, relate to the low incidence of OEC tumors. Here, we summarize the known case reports of OEC tumors, discuss the difficulties of correctly diagnosing them, and examine the possible reasons for their rare incidence. Understanding why OECs rarely form tumors may open avenues for new strategies to combat tumorigenesis in other regions of the nervous system.

Indexed as

Anterior cranial fossaGliomaOlfactory bulbOlfactory nervous systemSchwann cellSchwannoma

Identifiers

PMID31632194
PMCPMC6788004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.